GLP-1

Semaglutide is the new opiate crisis, and most of you are either currently lining up for it or know someone who is. I’m going to be unkind about this, and empathetic at the same time, because both sides of that sentence are true, and pretending otherwise is part of how this has gotten as bad as it has.

The empathetic part first. Losing weight in modern America is genuinely brutal. The food environment is engineered against you. Half of what is in the grocery store is hyperpalatable industrial product designed by entire R&D departments to override every satiety signal your body has. The dietary guidelines have been wrong for fifty years. The people you are supposed to trust — your doctor, your dietitian, the federal government — have, in many cases, been telling you exactly the wrong thing for your entire life. If you are forty-five and obese and tired and you finally went to your doctor and your doctor wrote you a prescription for Ozempic, I am not going to lecture you. The deck was stacked against you, on purpose, by people who profited from the stacking, and the drug being offered to you now is the next layer of the same scheme.

That is the empathetic part. Now the unkind part.

What the drug actually does

GLP-1 agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the next generation already in trials — work by mimicking a gut hormone that signals satiety to your brain and slows the rate at which food leaves your stomach. The result is that you eat less, because you are not hungry, and what you do eat sits in your gut for hours longer than it normally would. Over a year, the average user loses about twelve to fifteen percent of their body weight. The headlines call this a miracle. Pharma stock prices have detached from gravity. Novo Nordisk briefly became the most valuable company in Europe.

What the headlines do not say, or do not say loudly enough:

Up to forty percent of the weight you lose on these drugs is lean mass — muscle, bone, organ tissue. The scale moves dramatically. The body composition behind that scale movement is, in many cases, worse than the body you started with. You arrive at a lower number on the scale weaker, more sarcopenic, less metabolically active, and structurally fragile in a way you were not before. The “Ozempic face” — the gaunt, aged appearance everyone has noticed in celebrities — is not vanity gossip. It is what rapid weight loss without resistance training and adequate protein looks like in real time. It is also a preview of the rest of the body, which you cannot see in photos.

Stopping the drug means regaining most of the weight within a year. The trial data is unambiguous on this. Two-thirds of the lost weight comes back within twelve months of discontinuation. The drug does not fix the metabolic dysfunction underneath the obesity. The drug suppresses the appetite that is one of many symptoms of that dysfunction. Turn the suppressant off, the symptom returns, and the underlying condition is now worse — because you have less muscle, less bone, less metabolic infrastructure than you had before you started. The result is a population of people who are now medically required, for the rest of their lives, to inject a thousand-dollar-a-month drug to maintain a body composition they could have built and held with diet and lifting if they had been told the truth twenty years ago.

Then there are the side effects we are still discovering. Severe gastroparesis — a condition in which your stomach simply stops working — has surfaced in enough cases to trigger an active FDA investigation, and some of these cases appear to be permanent. Pancreatitis. Gallbladder disease. Thyroid C-cell tumors in the animal studies that were quietly waved off. Bone density loss. Mood changes the trials were not designed to catch. We do not know what twenty years of weekly subcutaneous injection of a synthetic gut hormone will do to a body, because no one has been on this drug for twenty years. The first generation of long-term users is being run, right now, in real time, on the people taking it.

This is the same script that ran with opioids in the 1990s, and it is being run by some of the same kinds of actors with some of the same kinds of incentives. Pharma identified a real and widespread problem (chronic pain, then; chronic obesity, now). Pharma developed a drug that addressed the symptom dramatically (pain relief, then; appetite suppression, now). Pharma funded the academic medicine, paid the key opinion leaders, captured the professional societies, and ran the marketing campaign that recoded the drug from “use sparingly in narrow circumstances” to “the standard of care for almost everyone with the underlying condition.” Doctors, trained at meetings sponsored by the manufacturer, dutifully prescribed it. Insurance, with mixed reluctance, started covering it. The drug became a lifestyle.

The opioid version of this killed several hundred thousand Americans before the casualties became impossible to ignore. The GLP-1 version is not going to kill people the same way — the failure mode is different — but the structural arc is identical. We are mass-medicating a population for a problem that is, at root, environmental and behavioral, with a permanent pharmaceutical intervention that does not fix the environment or the behavior, and that creates lifelong dependence on a manufactured substance whose long-term effects we cannot yet know because long-term has not yet happened.

The opioid crisis was an industry response to a population suffering from chronic pain that was, in many cases, downstream of obesity, sedentary lifestyle, depression, and a broken food environment. The GLP-1 crisis is an industry response to a population suffering from chronic obesity that is downstream of the same things. We have not addressed the upstream cause in either case. We have just kept selling drugs that mute the downstream signal.

A note for the biohackers

A specific note for the wellness-tech crowd that is currently microdosing GLP-1s for “metabolic optimization” — you are not optimizing anything. You are running an unsupervised long-term experiment on your own healthy body, using a drug whose chronic-use safety profile in non-obese populations is unknown, in pursuit of a body composition you could have built in eighteen months in the gym. You are doing this because the gym requires patience and the injection does not. The injection is, in your case, a literal cope, and the fact that you can describe the molecular mechanism of GLP-1 agonism in detail does not change that. The point of building a body is the building. The shortcut you took skipped the part that was actually load-bearing.

Every shortcut that doesn’t address the underlying cause is a cope. This is a hard sentence to write, because there are people I care about who are on these drugs, and I don’t want to make them feel worse than they already do. But empathy that lets the wrong solution stand isn’t empathy. It’s collusion.

The underlying cause of the obesity epidemic is a food environment that did not exist a hundred years ago, eaten by a population that is sedentary in a way no human population has ever been before, sleeping badly, lit wrong, stressed constantly, and surrounded by toxins. None of those conditions are addressed by an appetite suppressant. The appetite suppressant lets you live inside the broken environment without flinching. That is its function. It is a coping mechanism for a sick civilization, and like all coping mechanisms for sick civilizations, it converts patients into permanent customers and tells them they are being saved.

The body is not broken in the way the marketing implies. The body is doing exactly what an honest body would do given the inputs it is being asked to process. Fix the inputs. The body knows what to do with real food, real movement, real sleep, real sun, and real seasons. It has known for two million years. We are the first generation that decided to medicate around all of that instead of doing any of it.

There is no other way out of this. There has never been another way out of this. Every generation finds out, eventually, that the body was built for one set of conditions, that returning to those conditions makes the body work, and that all the technological end-runs around those conditions either fail or charge a price that turns out to be unaffordable.

Go ancient. Eat the animal. Lift the heavy thing. Walk the long distance. Sleep in the dark. See the sun at sunrise. Get cold. Get hot. Skip a meal. Skip a day. Get off the couch and onto the floor. Stop drinking. Stop scrolling. Stop optimizing for comfort. Build a body that can handle being a body. The protocol is two million years old, it is free, it works on every human alive, and it will not be patentable, which is precisely why no one is selling it to you on a billboard.

Go hard. You are going to feel like shit for the first month. You are going to be cranky. Your sleep will be weird. Your social life will be inconvenienced. The hardest part of this is not physical; the hardest part is admitting that you have been lied to, on purpose, your entire life, by people who profited from the lie, and that the way out is the boring obvious thing your great-grandmother would have recommended without thinking about it.

There is no shortcut. The shortcut is the trap. The shortcut, in this case, is also a needle, and the needle does not stop.

If you don’t believe the protocol works, look at the Amish.

The Amish are a real-world control population for what happens to a Western society of European descent that has, for religious reasons, opted out of nearly every modern technological convenience over the last hundred and fifty years. They eat real food, much of it from their own farms, prepared at home, in the traditional ways. They work physically — Amish men average around eighteen thousand steps a day, Amish women around fourteen thousand, both vastly more than the modern American average of around four thousand. They sleep in the dark. They go to bed when the sun goes down. They are exposed to almost none of the industrial chemicals, seed oils, and ultra-processed foods that the rest of us swim in.

The result, in the studies that have actually measured it, is a population with type 2 diabetes rates of two to three percent versus the modern American rate of about eleven percent. Obesity rates a fraction of the surrounding population’s. Lower cancer rates. Lower autism rates. Lower autoimmune rates. Lower rates of nearly every chronic disease the standard American is told is “just part of getting older.” They are not getting older differently. They are getting older the way humans have always gotten older when humans live the way humans were built to live.

This is not romanticism about the Amish. They have their own problems and I am not signing up for the buggy. The point is that they are the cleanest available natural experiment we have on the question of whether the modern lifestyle is actually causing the modern epidemic, and the answer the experiment returns is yes, completely, in every measurable way. Evolution is still there, lurking in the shadows behind every grocery store and every prescription pad. The Amish do not need a GLP-1 agonist because they are not living in the conditions that produce the symptom the drug suppresses. They are living in the conditions the body expected.

You can do the same thing without joining a religious order. Eat the animal. Move all day. Sleep in the dark. Skip the seed oils. Skip the candy. Skip the screens after sundown. Skip the drug. The body will respond, on the same biological timeline it has always responded on, regardless of what century you happen to be doing it in.

There is no shortcut. There is the work, and there is the cope. Pick the work.